Cytocare Inc.: The Irvine pharmaceuticals and medical-devices...

Cytocare Inc.: The Irvine pharmaceuticals and medical-devices company reported a profit of $240,877, or 5 cents a share, on revenue of $3 million. That compared to net income of $148,456, or 3 cents a share, on revenue of $2.5 million for the second quarter of 1991. For the first six months of 1992, profits declined 3% to $629,473, or 12 cents a share, from $649,990, or 13 cents a share, for the corresponding 1991 period. Revenue rose 26% to $6.3 million.